Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Eman AlHussain A. Gawad, Mevidette El Madani, Hanan Mostafa & Radwa Marwan Abdel halim. (2023) Precision medicine as a predictive factor for risk of hospitalization of recurrent ischemic stroke patients treated with low dose aspirin. A pilot study. Egyptian Journal of Anaesthesia 39:1, pages 157-166.
Read now
Read now
Pedro Ayuso, Yolanda Macías, Javier Gómez-Tabales, Elena García-Martín & José A. G. Agúndez. (2022) Molecular monitoring of patient response to painkiller drugs. Expert Review of Molecular Diagnostics 22:5, pages 545-558.
Read now
Read now
Yolanda Macías, Javier Gómez Tabales, Elena García-Martín & José A.G. Agúndez. (2020) An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding. Expert Opinion on Drug Metabolism & Toxicology 16:4, pages 319-332.
Read now
Read now
Matilde Capi, Giovanna Gentile, Luana Lionetto, Gerardo Salerno, Fabiola Cipolla, Martina Curto, Marina Borro & Paolo Martelletti. (2018) Pharmacogenetic considerations for migraine therapies. Expert Opinion on Drug Metabolism & Toxicology 14:11, pages 1161-1167.
Read now
Read now
Laura Cuzzolin, Flamina Bardanzellu & Vassilios Fanos. (2018) The dark side of ibuprofen in the treatment of patent ductus arteriosus: could paracetamol be the solution?. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 855-868.
Read now
Read now
Adriana Maria Calvo, Paulo Zupelari-Gonçalves, Thiago José Dionísio, Daniel Thomas Brozoski, Flávio Augusto Faria & Carlos Ferreira Santos. (2017) Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9. Journal of Pain Research 10, pages 1581-1589.
Read now
Read now
Elena García-Martín, Gabriela Canto & José AG Agúndez. (2013) Metabolic considerations of drugs in the treatment of allergic diseases. Expert Opinion on Drug Metabolism & Toxicology 9:11, pages 1437-1452.
Read now
Read now
Christian Hillstrom & Jan G Jakobsson. (2013)
Lornoxicam: pharmacology and usefulness to treat acute postoperative and musculoskeletal pain a narrative review. Expert Opinion on Pharmacotherapy 14:12, pages 1679-1694.
Read now
Read now
José A G Agúndez, Elena García-Martín, Hortensia Alonso-Navarro & Félix Javier Jiménez-Jiménez. (2013) Anti-Parkinson's disease drugs and pharmacogenetic considerations. Expert Opinion on Drug Metabolism & Toxicology 9:7, pages 859-874.
Read now
Read now
José AG Agúndez, María Isabel Lucena, Carmen Martínez, Raúl J Andrade, Miguel Blanca, Pedro Ayuso & Elena García-Martín. (2011) Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Expert Opinion on Drug Metabolism & Toxicology 7:7, pages 817-828.
Read now
Read now
Richard W Grant & Deborah J Wexler. (2010) Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testing. Expert Review of Cardiovascular Therapy 8:3, pages 339-343.
Read now
Read now
Articles from other publishers (66)
Samina Ali, Aran Yukseloglu, Colin J. Ross, Rhonda J. Rosychuk, Amy L. Drendel, Robin Manaloor, David W. Johnson, Sylvie Le May & Bruce Carleton. (2023) Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone. PAIN Reports 8:6, pages e1113.
Crossref
Crossref
Guilherme Suarez-Kurtz. (2023) Pharmacogenomic implications of the differential distribution of CYP2C9 metabolic phenotypes among Latin American populations. Frontiers in Pharmacology 14.
Crossref
Crossref
A. S. Zhiryakova, N. P. Denisenko, A. V. Kryukov, A. V. Matveev, K. B. Mirzaev & D. A. Sychev. (2023) Pharmacogenetic predictors of the safety of nonsteroidal anti-inflammatory drugs. Pharmacogenetics and Pharmacogenomics:1, pages 31-36.
Crossref
Crossref
Ami Mehta, Anal Desai, David Rudd, Ghizal Siddiqui, Cameron J. Nowell, Ziqiu Tong, Darren J. Creek, Prakriti Tayalia, Prasanna S. Gandhi & Nicolas H. Voelcker. (2022) Bio‐Mimicking Brain Vasculature to Investigate the Role of Heterogeneous Shear Stress in Regulating Barrier Integrity. Advanced Biology 6:12.
Crossref
Crossref
Andranik A. Muradian, Dmitry A. Sychev, Dmitry A. Blagovestnov, Demyan I. Petrov, Dmitry S. Skukin, Irina P. Epifanova, Zhannet A. Sozaeva, Anastasia A. Kachanova, Natalia P. Denisenko, Sherzod P. Abdullaev & Elena A. Grishina. (2022) Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome. Terapevticheskii arkhiv 94:5, pages 610-615.
Crossref
Crossref
Karina Elisa Rosales-Pérez, Gustavo Axel Elizalde-Velázquez, Leobardo Manuel Gómez-Oliván, José Manuel Orozco-Hernández, Jesús Daniel Cardoso-Vera, Gerardo Heredia-García, Hariz Islas-Flores, Sandra García-Medina & Marcela Galar-Martínez. (2022) Brain damage induced by contaminants released in a hospital from Mexico: Evaluation of swimming behavior, oxidative stress, and acetylcholinesterase in zebrafish (Danio rerio). Chemosphere 294, pages 133791.
Crossref
Crossref
Andranik Alexandrovich Muradian, Dmitry Alekseevich Sychev, Dmitry Alekseevich Blagovestnov, Zhannet Alimovna Sozaeva, Kristina Anatolyevna Akmalova, Michael Sergeevich Zastrozhin, Leyla Nabievna Kerimova, Vadim Teymurazovich Koroshvili & Irina Alexandrovna Epifanova. (2022)
The effect of
CYP2D6
and
CYP2C9
gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy
. Drug Metabolism and Personalized Therapy 37:1, pages 27-34.
Crossref
Crossref
N. P. Denisenko, Sh. P. Abdullaev, K. A. Akmalova, Zh. A. Sozaeva, A. A. Kachanova, M. S-Kh. Sozaeva, L. Z. Bolieva, E. A. Grishina & D. A. Sychev. (2022) Structure of the distribution of genetic determinants of the efficacy and safety of non-steroidal anti-inflammatory drugs in the Russian population: focus on CYP2C8, PTGS1 and PTGS2. Modern Rheumatology Journal 16:1, pages 60-67.
Crossref
Crossref
Shalini Roy Chowdhury, Oindrilla Dutta Gupta, Arnab Kumar Ghosh, Partha Sarathi Singha, Syed Benazir Firdaus & Klaus Klarskov. (2021) Genetic variations and epigenetic modulations in CYP genes: Implications in NSAID-treatment of arthritis patients. The Nucleus 64:3, pages 331-342.
Crossref
Crossref
Sherzod P. Abdullaev, Natalia P. Denisenko, Karin B. Mirzaev, Gregorii N. Shuev, Zhannet A. Sozaeva, Anastasia A. Kachanova, Suleiman N. Mammaev, Elvira A. Kasaeva, Danial M. Gafurov, Elena A. Grishina & Dmitry A. Sychev. (2021) CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups. Terapevticheskii arkhiv 93:11, pages 1334-1339.
Crossref
Crossref
Narmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, Eguzkiñe Ibarra-García, Itziar Palacios–Zabalza, Fernando Macías García, Julio iglesias García, María Piñeiro-Lamas, Luisa Ibáñez, Xavier Vidal, Lourdes Vendrell, Luis Martin-Arias, María Sáinz Gil, Verónica Velasco-González, Ángel Salgado-Barreira & Adolfo Figueiras. (2021) A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users. Scientific Reports 11:1.
Crossref
Crossref
Yolanda Macías, Jesús M. García-Menaya, Manuel Martí, Concepción Cordobés, Raquel Jurado-Escobar, José A. Cornejo-García, María J. Torres, Natalia Blanca-López, Gabriela Canto, Miguel Blanca, José J. Laguna, Joan Bartra, Ana Rosado, Javier Fernández, Elena García-Martín & José A. G. Agúndez. (2021) Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs. Frontiers in Pharmacology 12.
Crossref
Crossref
Navid Neyshaburinezhad, Hengameh Ghasim, Mohammadreza Rouini, Youssef Daali & Yalda H. Ardakani. (2021) Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human Data. Journal of Personalized Medicine 11:8, pages 804.
Crossref
Crossref
Andranik Alexandrovich Muradian, Dmitry Alekseevich Sychev, Dmitry Alekseevich Blagovestnov, Zhannet Alimovna Sozaeva, Kristina Anatolyevna Akmalova, Michael Sergeevich Zastrozhin, Leyla Nabievna Kerimova, Vadim Teymurazovich Koroshvili & Irina Alexandrovna Epifanova. (2021)
The effect of
CYP2D6
and
CYP2C9
gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy
. Drug Metabolism and Personalized Therapy 0:0.
Crossref
Crossref
L. McEvoy, D. F. Carr & M. Pirmohamed. (2021) Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity. Frontiers in Pharmacology 12.
Crossref
Crossref
Giovana M. Weckwerth, Thiago J. Dionísio, Yuri M. Costa, Bella L. Colombini-Ishiquiriama, Gabriela M. Oliveira, Elza A. Torres, Leonardo R. Bonjardim, Adriana M. Calvo, Troy Moore, Devin M. Absher & Carlos F. Santos. (2020) CYP450 polymorphisms and clinical pharmacogenetics of ibuprofen after lower third molar extraction. European Journal of Clinical Pharmacology 77:5, pages 697-707.
Crossref
Crossref
Elena García‐Martín, Jesús M. García‐Menaya, Gara Esguevillas, José A. Cornejo‐García, Inmaculada Doña, Raquel Jurado‐Escobar, María J. Torres, Natalia Blanca‐López, Gabriela Canto, Miguel Blanca, José J. Laguna, Joan Bartra, Ana Rosado, Javier Fernández, Concepción Cordobés & José A.G. Agúndez. (2021)
Deep sequencing of prostaglandin‐endoperoxide synthase (
PTGE)
genes reveals genetic susceptibility for cross‐reactive hypersensitivity to NSAID
. British Journal of Pharmacology 178:5, pages 1218-1233.
Crossref
Crossref
Neda Gholamian Dehkordi, Seyed Abbas Mirzaei & Fatemeh Elahian. (2020) Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness. Inflammopharmacology 29:1, pages 49-74.
Crossref
Crossref
Mengchun Chen, Wei Sun, Zhe Wang, Chengke Huang, Guoxin Hu, Yijie Chen & Ledan Wang. (2020) Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies. BMC Pharmacology and Toxicology 21:1.
Crossref
Crossref
Н.А. Михайловская & Т.Н. Слободин. (2020) Nonsteroidal Anti-Inflammatory Drugs: Risks and Benefits. Неврология и нейрохирургия. Восточная Европа:3, pages 414-434.
Crossref
Crossref
A. A. Muradyan, D. A. Blagovestnov, D. A. Sychev, P. A. Yartsev, M. L. Rogal, L. N. Kerimova, V. T. Koroshvili & I. A. Yepifanova. (2020) The Effect of Polymorphisms in the CYP2D6 and CYP2C9 Genes on the Clinical Efficacy of Tramadol and Ketorolac When Using the Accelerated Recovery Protocol in Patients With Uncomplicated Acute Calculous Cholecystitis Who Underwent Cholecystectomy. Russian Sklifosovsky Journal "Emergency Medical Care" 9:3, pages 391-399.
Crossref
Crossref
Thiago José Dionísio, Gabriela Moraes Oliveira, Marina Morettin, Flavio Cardoso Faria, Carlos Ferreira Santos & Adriana Maria Calvo. (2020) Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography–tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole. PLOS ONE 15:8, pages e0236297.
Crossref
Crossref
Vera Kim, Thijs van der Wal, Miriam Yumie Nishi, Luciana Ribeiro Montenegro, Flair Jose Carrilho, Yujin Hoshida & Suzane Kioko Ono. (2020) Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transporters. Pharmacogenomics 21:9, pages 575-586.
Crossref
Crossref
I. Maslova, N. Mykhailovska & T. Slobodin. (2020) CYP2C9 Polymorphism Study in Patients with Acute Back Pain and its Impact on the Effectiveness of Treatment with the Non-Steroidal Anti-Inflammatory Drugs. Lviv clinical bulletin 1:29, pages 34-38.
Crossref
Crossref
A.E. Shindler, E.L. Hill-Yardin, S. Petrovski, N. Bishop & A.E. Franks. (2020) A preliminary study of pharmacogenetic biomarkers for individuals with autism and gastrointestinal dysfunction. Research in Autism Spectrum Disorders 71, pages 101516.
Crossref
Crossref
Rodney A. Gabriel, Brittany N. Burton, Richard D. Urman & Ruth S. Waterman. (2020) Genomics Testing and Personalized Medicine in the Preoperative Setting. Surgical Oncology Clinics of North America 29:1, pages 73-86.
Crossref
Crossref
Stefan C. Zajic, Joseph P. Jarvis, Pan Zhang, Kaveri D. Rajula, Andrew Brangan, Ruth Brenner, Michael P. Dempsey & Michael F. Christman. (2019) Individuals with CYP2C8 and CYP2C9 reduced metabolism haplotypes self-adjusted ibuprofen dose in the Coriell Personalized Medicine Collaborative. Pharmacogenetics and Genomics 29:3, pages 49-57.
Crossref
Crossref
M. V. Leonova & E. E. Alimova. (2019) Pharmacogenetics of non-steroidal anti-inflammatory drugs: existing problems for clinical practice. Medical Council:21, pages 204-209.
Crossref
Crossref
Nurullah Akkoc. (2018) Personalized Axial Spondyloarthritis Care. Current Treatment Options in Rheumatology 4:2, pages 158-173.
Crossref
Crossref
Pavan K. Mukthinuthalapati, Robert J. Fontana, Raj Vuppalanchi, Naga Chalasani & Marwan Ghabril. (2018) Celecoxib-induced Liver Injury. Journal of Clinical Gastroenterology 52:2, pages 114-122.
Crossref
Crossref
N. R. Srinivas. (2017) Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury. Alimentary Pharmacology & Therapeutics 46:7, pages 706-707.
Crossref
Crossref
Tracy A. Manuck. (2017) Refining Pharmacologic Research to Prevent and Treat Spontaneous Preterm Birth. Frontiers in Pharmacology 8.
Crossref
Crossref
Maria Kulecka, Andrzej Habior, Agnieszka Paziewska, Krzysztof Goryca, Michalina Dąbrowska, Filip Ambrozkiewicz, Bożena Walewska-Zielecka, Andrzej Gabriel, Michal Mikula & Jerzy Ostrowski. (2017) Clinical Applicability of Whole-Exome Sequencing Exemplified by a Study in Young Adults with the Advanced Cryptogenic Cholestatic Liver Diseases. Gastroenterology Research and Practice 2017, pages 1-8.
Crossref
Crossref
Flaminia Bardanzellu, Paola Neroni, Angelica Dessì & Vassilios Fanos. (2017) Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?. BioMed Research International 2017, pages 1-25.
Crossref
Crossref
Gemma Amo, José A. Cornejo-García, Jesus M. García-Menaya, Concepcion Cordobes, M. J. Torres, Gara Esguevillas, Cristobalina Mayorga, Carmen Martinez, Natalia Blanca-Lopez, Gabriela Canto, Alfonso Ramos, Miguel Blanca, José A. G. Agúndez & Elena García-Martín. (2016) FCERI and Histamine Metabolism Gene Variability in Selective Responders to NSAIDS. Frontiers in Pharmacology 7.
Crossref
Crossref
Valon Krasniqi, Aleksandar Dimovski, Iva Klarica Domjanović, Ivan Bilić & Nada Božina. (2016) How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity / Kako polimorfizmi gena citokroma P450 utječu na metabolizam i toksičnost ibuprofena i diklofenaka. Archives of Industrial Hygiene and Toxicology 67:1, pages 1-8.
Crossref
Crossref
Janne T. Backman, Anne M. Filppula, Mikko Niemi & Pertti J. Neuvonen. (2015) Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacological Reviews 68:1, pages 168-241.
Crossref
Crossref
. 2016. Diagnostic Pathology: Gastrointestinal. Diagnostic Pathology: Gastrointestinal
566
571
.
Cheedy Jaja, Latanya Bowman, Leigh Wells, Niren Patel, Hongyan Xu, Matt Lyon & Abdullah Kutlar. (2015)
Preemptive Genotyping of
CYP2C8
and
CYP2C9
Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management
. Clinical and Translational Science 8:4, pages 272-280.
Crossref
Crossref
K.D. Rainsford & Ingvar Bjarnason. 2015. Ibuprofen. Ibuprofen
363
429
.
José AG Agúndez, Miguel Blanca, José A Cornejo-García & Elena García-Martín. (2015) Pharmacogenomics of cyclooxygenases. Pharmacogenomics 16:5, pages 501-522.
Crossref
Crossref
Rajeshwary Ghosh, Azra Alajbegovic & Aldrin V. Gomes. (2015) NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species. Oxidative Medicine and Cellular Longevity 2015, pages 1-25.
Crossref
Crossref
Piotr K. Janicki. 2015. Treatment of Chronic Pain by Medical Approaches. Treatment of Chronic Pain by Medical Approaches
21
31
.
Mukesh Verma. (2014) Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?. Personalized Medicine 11:8, pages 761-771.
Crossref
Crossref
José A. G. Agúndez, Félix J. Jiménez-Jiménez, Hortensia Alonso-Navarro & Elena GarcÃa-MartÃn. (2014) Drug and xenobiotic biotransformation in the blood–brain barrier: a neglected issue. Frontiers in Cellular Neuroscience 8.
Crossref
Crossref
José A. G. Agúndez, Gara Esguevillas, Gemma Amo & Elena GarcÃa-MartÃn. (2014) Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs. Frontiers in Pharmacology 5.
Crossref
Crossref
Pierre BaumannJosé AG AgúndezElena García-Martin. 2014. CYP2D6: Genetics, Pharmacology and Clinical Relevance. CYP2D6: Genetics, Pharmacology and Clinical Relevance
118
133
.
Camilla Stephens, Maria Lucena & Raúl Andrade. 2014. Handbook of Personalized Medicine. Handbook of Personalized Medicine
1293
1333
.
Roc?o Prieto-P?rez, Dolores Ochoa, Teresa Cabaleiro, Manuel Rom?n, Sergio Daniel S?nchez-Rojas, Mar?a Taleg?n & Francisco Abad-Santos. (2013)
Evaluation of the relationship between polymorphisms in
CYP2C8
and
CYP2C9
and the pharmacokinetics of celecoxib
. The Journal of Clinical Pharmacology 53:12, pages 1261-1267.
Crossref
Crossref
Roman Cregg, Giovanna Russo, Anthony Gubbay, Ruth Branford & Hiroe Sato. (2013) Pharmacogenetics of analgesic drugs. British Journal of Pain 7:4, pages 189-208.
Crossref
Crossref
S C Sim, M Kacevska & M Ingelman-Sundberg. (2012) Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects. The Pharmacogenomics Journal 13:1, pages 1-11.
Crossref
Crossref
Svatopluk Světlík, Karolína Hronová, Hana Bakhouche, Olga Matoušková & Ondřej Slanař. (2013) Pharmacogenetics of Chronic Pain and Its Treatment. Mediators of Inflammation 2013, pages 1-23.
Crossref
Crossref
Piotr K. Janicki. 2013. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches
23
33
.
J E Wyatt, W L Pettit & S Harirforoosh. (2012) Pharmacogenetics of nonsteroidal anti-inflammatory drugs. The Pharmacogenomics Journal 12:6, pages 462-467.
Crossref
Crossref
Zaher A. Radi. 2012. Comparative Pathophysiology and Toxicology of Cyclooxygenases. Comparative Pathophysiology and Toxicology of Cyclooxygenases
11
71
.
Bruce Hullett, Sam Salman, Sean J. O'Halloran, Deborah Peirce, Kylie Davies & Kenneth F. Ilett. (2012) Development of a Population Pharmacokinetic Model for Parecoxib and Its Active Metabolite Valdecoxib after Parenteral Parecoxib Administration in Children. Anesthesiology 116:5, pages 1124-1133.
Crossref
Crossref
Vita Dolžan. 2012. Pharmacogenetics and Individualized Therapy. Pharmacogenetics and Individualized Therapy
13
80
.
Jolanda S. van Leeuwen, Betül Ünlü, Nico P.E. Vermeulen & J. Chris Vos. (2012) Differential involvement of mitochondrial dysfunction, cytochrome P450 activity, and active transport in the toxicity of structurally related NSAIDs. Toxicology in Vitro 26:2, pages 197-205.
Crossref
Crossref
K. D. RainsfordK. D. Rainsford. 2012. Ibuprofen: Pharmacology, Therapeutics and Side Effects. Ibuprofen: Pharmacology, Therapeutics and Side Effects
91
122
.
Valery Elie, Tiphaine de Beaumais, May Fakhoury & Evelyne Jacqz-Aigrain. (2011) Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs. Pharmacogenomics 12:6, pages 827-843.
Crossref
Crossref
Jing Li, Luyong Zhang, Hang Zhou, Mark Stoneking & Kun Tang. (2011) Global patterns of genetic diversity and signals of natural selection for human ADME genes. Human Molecular Genetics 20:3, pages 528-540.
Crossref
Crossref
Sarah C. Sim & Magnus Ingelman-Sundberg. (2011) Pharmacogenomic biomarkers: new tools in current and future drug therapy. Trends in Pharmacological Sciences 32:2, pages 72-81.
Crossref
Crossref
Eline M. Rodenburg, Bruno H. Ch. Stricker & Loes E. Visser. (2011) Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands. British Journal of Clinical Pharmacology 71:1, pages 95-104.
Crossref
Crossref
Annette J Vangsted, Karen S?eby, Tobias W Klausen, Niels Abildgaard, Niels F Andersen, Peter Gimsing, Henrik Gregersen, Ulla Vogel, Thomas Werge & Henrik B Rasmussen. (2010) No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma. BMC Cancer 10:1.
Crossref
Crossref
Xavier Durrmeyer, Shushanik Hovhannisyan, Yves M?dard, Evelyne Jacqz-Aigrain, Fabrice Decobert, J?rome Barre, Corinne Alberti, Yannick Aujard, Claude Danan & Olivier Baud. (2010) Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?. PLoS ONE 5:8, pages e12329.
Crossref
Crossref
Ulrike M Stamer, Lan Zhang & Frank Stüber. (2010) Personalized therapy in pain management: where do we stand?. Pharmacogenomics 11:6, pages 843-864.
Crossref
Crossref